We are live on ! Find out more
FMS icon

Fresenius Medical Care

186 hedge funds and large institutions have $697M invested in Fresenius Medical Care in 2017 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 56 increasing their positions, 65 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

12% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 26

5% more capital invested

Capital invested by funds: $665M → $697M (+$31.9M)

1% more funds holding

Funds holding: 185186 (+1)

0.26% more ownership

Funds ownership: 5.12%5.38% (+0.26%)

14% less repeat investments, than reductions

Existing positions increased: 56 | Existing positions reduced: 65

Holders
186
Holders Change
+1
Holders Change %
+0.54%
% of All Funds
4.63%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
29
Increased
56
Reduced
65
Closed
26
Calls
Puts
Net Calls
Net Calls Change

FMS Hedge Fund Activity: Q1 2017 in Review

186 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Fresenius Medical Care (FMS) for Q1 2017, worth a combined $697M — up 4.8% from $665M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new FMS positions and 26 closed out — a net gain of 3 holders — while 56 added to existing stakes and 65 trimmed.

The largest buyer was Millennium Management, opening a new position worth an estimated $11.8M. The largest seller was Hardman Johnston Global Advisors, cutting an estimated $12.2M.

  • 186 institutional investors held Fresenius Medical Care (FMS) as of Q1 2017, up from 185 in Q4 2016.
  • Funds reported $697M of Fresenius Medical Care stock for Q1 2017, up 4.8% quarter-over-quarter.
  • 29 funds opened new Fresenius Medical Care positions in Q1 2017 and 26 closed out, a net change of +3 holders.
  • The largest Fresenius Medical Care buyer in Q1 2017 was Millennium Management, an estimated $11.8M added.
  • The largest Fresenius Medical Care seller in Q1 2017 was Hardman Johnston Global Advisors, an estimated $12.2M sold.

Based on aggregated 13F filings for Q1 2017.